大塚ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/31 | 4,242 | 4,307 | 4,232 | 4,232 | -38 | -0.9% | 1,549,200 |
| 2022/03/30 | 4,300 | 4,319 | 4,229 | 4,270 | -1 | ±0% | 871,600 |
| 2022/03/29 | 4,241 | 4,272 | 4,219 | 4,271 | +38 | +0.9% | 865,800 |
| 2022/03/28 | 4,258 | 4,259 | 4,211 | 4,233 | -34 | -0.8% | 558,400 |
| 2022/03/25 | 4,268 | 4,272 | 4,208 | 4,267 | +20 | +0.5% | 797,600 |
| 2022/03/24 | 4,265 | 4,267 | 4,211 | 4,247 | -23 | -0.5% | 909,200 |
| 2022/03/23 | 4,200 | 4,284 | 4,185 | 4,270 | +122 | +2.9% | 1,137,000 |
| 2022/03/22 | 4,188 | 4,207 | 4,135 | 4,148 | -18 | -0.4% | 1,693,900 |
| 2022/03/18 | 4,174 | 4,194 | 4,105 | 4,166 | +41 | +1% | 1,852,500 |
| 2022/03/17 | 4,108 | 4,130 | 4,067 | 4,125 | +101 | +2.5% | 1,446,900 |
| 2022/03/16 | 4,030 | 4,060 | 4,023 | 4,024 | +51 | +1.3% | 925,700 |
| 2022/03/15 | 3,935 | 3,987 | 3,920 | 3,973 | +50 | +1.3% | 662,700 |
| 2022/03/14 | 3,965 | 4,023 | 3,916 | 3,923 | -6 | -0.2% | 972,400 |
| 2022/03/11 | 3,947 | 3,966 | 3,901 | 3,929 | -53 | -1.3% | 1,360,800 |
| 2022/03/10 | 3,897 | 3,997 | 3,879 | 3,982 | +100 | +2.6% | 1,425,100 |
| 2022/03/09 | 3,845 | 3,909 | 3,841 | 3,882 | +45 | +1.2% | 1,268,000 |
| 2022/03/08 | 3,851 | 3,887 | 3,831 | 3,837 | -54 | -1.4% | 885,200 |
| 2022/03/07 | 3,900 | 3,908 | 3,847 | 3,891 | -47 | -1.2% | 852,100 |
| 2022/03/04 | 3,971 | 3,982 | 3,923 | 3,938 | -7 | -0.2% | 759,900 |
| 2022/03/03 | 3,900 | 3,957 | 3,888 | 3,945 | +71 | +1.8% | 758,100 |
| 2022/03/02 | 3,868 | 3,891 | 3,852 | 3,874 | -64 | -1.6% | 944,900 |
| 2022/03/01 | 4,015 | 4,029 | 3,931 | 3,938 | -25 | -0.6% | 988,900 |
| 2022/02/28 | 3,935 | 3,987 | 3,935 | 3,963 | +31 | +0.8% | 1,186,200 |
| 2022/02/25 | 3,936 | 3,949 | 3,892 | 3,932 | +28 | +0.7% | 882,500 |
| 2022/02/24 | 3,957 | 3,961 | 3,871 | 3,904 | -82 | -2.1% | 1,076,700 |
| 2022/02/22 | 4,024 | 4,024 | 3,932 | 3,986 | -44 | -1.1% | 616,700 |
| 2022/02/21 | 4,019 | 4,043 | 3,989 | 4,030 | -23 | -0.6% | 483,500 |
| 2022/02/18 | 3,972 | 4,057 | 3,971 | 4,053 | +52 | +1.3% | 871,400 |
| 2022/02/17 | 4,006 | 4,030 | 3,954 | 4,001 | -43 | -1.1% | 1,091,600 |
| 2022/02/16 | 4,022 | 4,057 | 4,008 | 4,044 | +46 | +1.2% | 831,000 |
| 2022/02/15 | 3,999 | 4,032 | 3,972 | 3,998 | +34 | +0.9% | 798,200 |
| 2022/02/14 | 3,988 | 4,044 | 3,954 | 3,964 | -118 | -2.9% | 955,400 |
| 2022/02/10 | 4,080 | 4,099 | 4,025 | 4,082 | +17 | +0.4% | 1,157,100 |
| 2022/02/09 | 4,124 | 4,124 | 4,050 | 4,065 | -46 | -1.1% | 867,400 |
| 2022/02/08 | 4,122 | 4,139 | 4,092 | 4,111 | +20 | +0.5% | 712,100 |
| 2022/02/07 | 4,040 | 4,099 | 4,029 | 4,091 | +34 | +0.8% | 579,200 |
| 2022/02/04 | 4,017 | 4,063 | 4,005 | 4,057 | +17 | +0.4% | 630,000 |
| 2022/02/03 | 3,992 | 4,040 | 3,980 | 4,040 | +35 | +0.9% | 895,800 |
| 2022/02/02 | 3,934 | 4,031 | 3,929 | 4,005 | +101 | +2.6% | 1,187,600 |
| 2022/02/01 | 3,918 | 3,959 | 3,898 | 3,904 | -14 | -0.4% | 942,700 |
| 2022/01/31 | 3,910 | 3,941 | 3,845 | 3,918 | -45 | -1.1% | 1,386,600 |
| 2022/01/28 | 4,064 | 4,080 | 3,951 | 3,963 | -129 | -3.2% | 1,831,800 |
| 2022/01/27 | 4,166 | 4,173 | 4,054 | 4,092 | -42 | -1% | 667,300 |
| 2022/01/26 | 4,183 | 4,192 | 4,124 | 4,134 | -69 | -1.6% | 883,800 |
| 2022/01/25 | 4,180 | 4,203 | 4,138 | 4,203 | +2 | ±0% | 790,900 |
| 2022/01/24 | 4,153 | 4,206 | 4,145 | 4,201 | +48 | +1.2% | 779,000 |
| 2022/01/21 | 4,123 | 4,170 | 4,101 | 4,153 | +23 | +0.6% | 569,700 |
| 2022/01/20 | 4,087 | 4,182 | 4,087 | 4,130 | +55 | +1.3% | 761,500 |
| 2022/01/19 | 4,109 | 4,130 | 4,057 | 4,075 | -56 | -1.4% | 856,700 |
| 2022/01/18 | 4,164 | 4,190 | 4,126 | 4,131 | -17 | -0.4% | 549,900 |
651～
700
件表示中 / 3412件
類似銘柄と比較する
現在ご覧いただいている「大塚ＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大塚ＨＤ | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| 第一三共 | 443,500円 | +14.3% | +20.1% | 1.35% | 37.27倍 | 5.17倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 411,300円 | +5.1% | +76.2% | 4.77% | 95.87倍 | 0.94倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム
